D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TDOC holding history
Teladoc Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TDOC overviewAll 13F holders of TDOCFull Q2 2026 holdings
- Shares (Q2 2026)
- 639,209
- Value
- $5.42M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 639,209 | $5.42M | <0.1% | −41,950−6.2% | Reduced | Holders |
| Q1 2026 | 681,159 | $3.71M | <0.1% | +139,879+25.8% | Added | Holders |
| Q4 2025 | 541,280 | $3.79M | <0.1% | +246,844+83.8% | Added | Holders |
| Q3 2025 | 294,436 | $2.28M | <0.1% | +153,224+108.5% | Added | Holders |
| Q2 2025 | 141,212 | $1.23M | <0.1% | −567,531−80.1% | Reduced | Holders |
| Q1 2025 | 708,743 | $5.64M | <0.1% | +501,746+242.4% | Added | Holders |
| Q4 2024 | 206,997 | $1.88M | <0.1% | +152,926+282.8% | Added | Holders |
| Q3 2024 | 54,071 | $496.4K | <0.1% | −136,312−71.6% | Reduced | Holders |
| Q2 2024 | 190,383 | $1.86M | <0.1% | −386,104−67.0% | Reduced | Holders |
| Q1 2024 | 576,487 | $8.70M | <0.1% | +313,867+119.5% | Added | Holders |
| Q4 2023 | 262,620 | $5.66M | <0.1% | +145,001+123.3% | Added | Holders |
| Q3 2023 | 117,619 | $2.19M | <0.1% | −622,413−84.1% | Reduced | Holders |
| Q2 2023 | 740,032 | $18.7M | <0.1% | −751,913−50.4% | Reduced | Holders |
| Q1 2023 | 1,491,945 | $38.6M | 0.1% | −1,081,897−42.0% | Reduced | Holders |
| Q4 2022 | 2,573,842 | $60.9M | 0.1% | −447,104−14.8% | Reduced | Holders |
| Q3 2022 | 3,020,946 | $76.6M | 0.1% | +948,465+45.8% | Added | Holders |
| Q2 2022 | 2,072,481 | $68.8M | 0.1% | +1,668,289+412.7% | Added | Holders |
| Q1 2022 | 404,192 | $29.2M | <0.1% | +207,165+105.1% | Added | Holders |
| Q4 2021 | 197,027 | $18.1M | <0.1% | −161,003−45.0% | Reduced | Holders |
| Q3 2021 | 358,030 | $45.4M | 0.1% | +205,527+134.8% | Added | Holders |
| Q2 2021 | 152,503 | $25.4M | <0.1% | +32,501+27.1% | Added | Holders |
| Q1 2021 | 120,002 | $21.8M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.